scholarly article | Q13442814 |
P2093 | author name string | Giaccia AJ | |
Chen EY | |||
Mazure NM | |||
Laderoute KR | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hypoxia | Q105688 |
endothelium | Q111140 | ||
P304 | page(s) | 3322-3331 | |
P577 | publication date | 1997-11-01 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element | |
P478 | volume | 90 |
Q28476652 | 1, 9-Pyrazoloanthrones downregulate HIF-1α and sensitize cancer cells to cetuximab-mediated anti-EGFR therapy |
Q58712110 | A Review of Molecular Responses of Catfish to Bacterial Diseases and Abiotic Stresses |
Q42175358 | A novel targeted angiogenesis technique using VEGF conjugated magnetic nanoparticles and in-vitro endothelial barrier crossing |
Q35574943 | Acacetin inhibits VEGF expression, tumor angiogenesis and growth through AKT/HIF-1α pathway |
Q40118264 | Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells |
Q39737660 | Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. |
Q34150587 | Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease |
Q24676614 | Akt1 in endothelial cell and angiogenesis |
Q24648140 | Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo |
Q42482049 | Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis |
Q35291703 | Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells |
Q34108131 | Angiogenic molecules and mechanisms in breast cancer |
Q41973667 | Angiogenic signalling pathways altered in gliomas: selection mechanisms for more aggressive neoplastic subpopulations with invasive phenotype |
Q34306523 | Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture |
Q90150620 | Anti-tumor Effect of Ginkgo biloba Exocarp Extracts on B16 Melanoma Bearing Mice Involving P I3K/Akt/HIF-1α/VEGF Signaling Pathways |
Q23918911 | Arsenite induces HIF-1a and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells |
Q34290708 | Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death |
Q37441608 | Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells |
Q37439503 | Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target |
Q34147934 | COPing with hypoxia |
Q39451271 | Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide |
Q36045952 | Clinical experience with monoclonal antibodies to epidermal growth factor receptor |
Q45798976 | Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer |
Q37335861 | Coregistration of ultrasonography and magnetic resonance imaging with a preliminary investigation of the spatial colocalization of vascular endothelial growth factor receptor 2 expression and tumor perfusion in a murine tumor model |
Q37731308 | D11-Mediated Inhibition of Protein Kinase CK2 Impairs HIF-1α-Mediated Signaling in Human Glioblastoma Cells. |
Q42230465 | Dysregulation of angiogenesis-specific signalling in adult testis results in xenograft degeneration. |
Q37565235 | Effects of tumor microenviromental factors on VEGF expression |
Q36962774 | Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment |
Q36438366 | Establishing a link between oncogenes and tumor angiogenesis |
Q38751296 | FAT1 is a novel upstream regulator of HIF1α and invasion of high grade glioma |
Q37901411 | From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension |
Q35051647 | Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells |
Q36021580 | Genetic and hypoxic regulation of angiogenesis in gliomas |
Q35889104 | Ginkgolide B preconditioning protects neurons against ischaemia-induced apoptosis |
Q39908058 | Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress |
Q35856898 | Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner |
Q37269341 | Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations |
Q33746822 | HIF-1alpha: a valid therapeutic target for tumor therapy |
Q49295236 | HIF-1α contributes to hypoxia adaptation of the naked mole rat. |
Q24801701 | Hypoxia and oxidative stress in breast cancer. Hypoxia signalling pathways |
Q34062916 | Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires transforming growth factor-beta/Smad3 signaling |
Q36288611 | Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia |
Q26768230 | Hypoxia-Inducible Factors (HIFs) and Phosphorylation: Impact on Stability, Localization, and Transactivity |
Q41898495 | Hypoxia-induced down-regulation of CYP1A1/1A2 and up-regulation of CYP3A6 involves serum mediators |
Q37464073 | Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction |
Q35786778 | Hypoxia-inducible factor-1α regulates KCNMB1 expression in human pulmonary artery smooth muscle cells |
Q37395006 | Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis |
Q28077444 | Implications of Hypoxia in Breast Cancer Metastasis to Bone |
Q42280223 | Inhibitory effects of 17β-estradiol or a resveratrol dimer on hypoxia-inducible factor-1α in genioglossus myoblasts: Involvement of ERα and its downstream p38 MAPK pathways |
Q40468150 | Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways. |
Q39308780 | Intra-islet endothelial cell and β-cell crosstalk: Implication for islet cell transplantation |
Q47673795 | Involvement of Akt1/protein kinase Balpha in tumor conditioned medium-induced endothelial cell migration and survival in vitro |
Q38819850 | Involvement of Numb-mediated HIF-1α inhibition in anti-proliferative effect of PNA-antimiR-182 in trastuzumab-sensitive and -resistant SKBR3 cells |
Q40403536 | Involvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells |
Q26851470 | Leukocyte driven-decidual angiogenesis in early pregnancy |
Q28145476 | Loss of PTEN facilitates HIF-1-mediated gene expression |
Q36591258 | Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters |
Q35151099 | Mechanism and its regulation of tumor-induced angiogenesis |
Q37620679 | Metabolism addiction in pancreatic cancer |
Q43855694 | Metabolite control of angiogenesis: angiogenic effect of citrate |
Q35064453 | Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade |
Q28365260 | Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway |
Q39674949 | Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. |
Q34199098 | Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways |
Q28396795 | PI3K at the crossroads of tumor angiogenesis signaling pathways |
Q21129332 | PI3K/AKT/mTOR Pathway in Angiogenesis |
Q60921025 | PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review) |
Q28383083 | PI3K/PTEN signaling in angiogenesis and tumorigenesis |
Q37808385 | PI3Kinase signaling in glioblastoma |
Q28391415 | Peroxidase activation of cytoglobin by anionic phospholipids: Mechanisms and consequences |
Q37116110 | Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells |
Q54980764 | Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics. |
Q35111129 | Pleiotropic and age-dependent effects of decreased protein modification by O-linked N-acetylglucosamine on pancreatic β-cell function and vascularization. |
Q28388934 | Progress and prospects of reactive oxygen species in metal carcinogenesis |
Q42734986 | Protein kinase B (akt) promotes pathological angiogenesis in murine model of oxygen-induced retinopathy |
Q42991716 | Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. |
Q34130984 | Protein phosphatase 2A mediates dormancy of glioblastoma multiforme-derived tumor stem-like cells during hypoxia |
Q88623710 | Pulmonary artery smooth muscle cell HIF-1α regulates endothelin expression via microRNA-543 |
Q35826582 | Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1alpha-mediated tumor apoptotic switch |
Q36397313 | Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy. |
Q37462587 | Regulation of HIF-1α activity by overexpression of thioredoxin is independent of thioredoxin reductase status |
Q24540159 | Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. |
Q24610199 | Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha |
Q28352584 | Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival |
Q35220339 | Repetitive acute intermittent hypoxia increases expression of proteins associated with plasticity in the phrenic motor nucleus |
Q37594844 | Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. |
Q38668940 | Targeting the RhoGTPase/ROCK pathway for the treatment of VHL/HIF pathway-driven cancers. |
Q34129360 | Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma |
Q36572565 | The Akt1-eNOS axis illustrates the specificity of kinase-substrate relationships in vivo |
Q33599964 | The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway |
Q34425462 | The hemostatic system and angiogenesis in malignancy. |
Q37454384 | The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications. |
Q37079708 | The role of hypoxia-inducible factors in tumorigenesis. |
Q42217527 | Tipifarnib in the treatment of acute myeloid leukemia |
Q26798822 | Tumour Angiogenesis and Angiogenic Inhibitors: A Review |
Q24804703 | Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis |
Q35689605 | Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? |
Q35834542 | Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword |
Q36402077 | Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus |
Q34510374 | Vascular growth factors in cerebral ischemia. |
Search more.